GC Therapeutics raises $75 million to transform cell therapy
Longevity Technology - 23-Sep-2024The startup leverages its TFome™ platform for rapid and efficient iPSC programming
Join the club for FREE to access the whole archive and other member benefits.
Harvard Professor and PersonalGenomes.org Founder
George McDonald Church is an American geneticist, molecular engineer, and chemist. As of 2015, he is Robert Winthrop Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and MIT, and was a founding member of the Wyss Institute for Biologically Inspired Engineering at Harvard. As of March 2017, Church serves as a member of the Bulletin of the Atomic Scientists' Board of Sponsors.
Professor at Harvard & MIT, Director of PersonalGenomes.org, which provides the world's only open-access information on human Genomic, Environmental & Trait data (GET). His 1984 Harvard PhD included the first methods for direct genome sequencing, molecular multiplexing & barcoding. These led to the first genome sequence (pathogen, Helicobacter pylori) in 1994 . His innovations have contributed to nearly all "next generation" DNA sequencing methods and companies (CGI-BGI, Life, Illumina, Nanopore). This plus his lab's work on chip-DNA-synthesis, gene editing and stem cell engineering resulted in founding additional application-based companies spanning fields of medical diagnostics ( Knome/PierianDx, Alacris, Nebula Genomics, Veritas Genetics ) & synthetic biology / therapeutics (AbVitro/Juno, Gen9/Ginkgo, Editas, Egenesis, enEvolv, WarpDrive ).
From Modern Healthspans interview (last few minutes of last video) on YouTube.
Visit website: https://en.wikipedia.org/wiki/George_M._Church
See also: Nebula Genomics - DNA testing company.
Details last updated 21-Nov-2019
03-Jun-2022 to 05-Jun-2022
Conference about cryonics and life extension organized by Alcor with David Chalmers and George Church as featured speakers
DNA nanobots will soon be tried in a critically ill leukemia patient
11-Aug-2022 to 14-Aug-2022
Virtual Conference for Rejuvenation Biotechnology and Life Extension organized by Lifespan Extension Advocacy Foundation
03-May-2023
Online event with George Church on Gene Therapy and Longevity organized by Oxford Society of Ageing and Longevity (FREE)
28-Sep-2022 to 30-Sep-2022
Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger and Dr. Tobias Reichmuth
13-May-2024
Conference about longevity, its social changes and aging organised by Vitalism Foundation (Cofrentes, Spain)
05-Dec-2023 to 06-Dec-2023
Summit speaking about the future of medicine, eliminating diseases of aging brought by Longevity SF
18-Sep-2022 to 20-Sep-2022
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Live stream of XPRIZE Healthspan launch on YouTube
The startup leverages its TFome™ platform for rapid and efficient iPSC programming
10 years of functional age-reversal in 65-80 year olds within the next 7 years... bring it on!!!
Is involved in many longevity companies ranging from improving gene therapy delivery to supplements
Treatment used proprietary CMV vector which is able to deliver multiple genes into the nucleus
Produces personalised tips by comparing phone/wearables data with UK Biobank
Discusses animal trials, potential human trials, reeducating the FDA and improvements in technology
Connecting aspiring longevity founders with mentors to drive innovation in anti-ageing biotech
New technologies uncovered missing genes in human genome - yet to be peer-reviewed
George Church has grand plans to make better cells
Your genomic data will be owned by you - can sell it if you want to
Decentralization of DNA editing techniques will lead to regulatory and public health problems
Rejuvenate Bio is cofounded by George Church of Harvard Medical School. Will make animals “young...
In principle, a gene therapy can do everything a drug can. Should perform more effectively and m...
Harvard Medical School use CRISPR/Cas9 gene-editing technology to inactivate 62 porcine endogenou...